Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03985098 · ClinicalTrials.gov registry record · NA
Motivational Interviewing (MI) Intervention to Improve Adherence
A NA study, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 727
- Enrollment target
NCT03985098: Completed NA study, sponsored by University of Houston.
NCT03985098 is a NA study that has completed, run by University of Houston. The registered enrollment target is 727 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03985098, a NA study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 727 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effectiveness of a telephone motivational interviewing intervention by pharmacy students in enhancing adherence to angiotensin converting enzyme inhibitors (ACEI)/ angiotensin receptor blockers (ARB) (ACE/ARBs) among patients with diabetes and hypertension in a Medicare advantage plan.
Primary Outcome
Proportion of days covered (PDC): measured by examining refill data, both as a continuous measure as well as a categorical measure with a PDC of 0.8 or more considered adherent. It ranges from 0-1.
Interventions
- BEHAVIORAL Motivational interviewing intervention arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 727 participants |
| Start Date | 2019-05-29 |
| Est. Completion | 2022-03-22 |
| Phase | NA |
What the finished NCT03985098 record still lists
NCT03985098 is an interventional study that assigns participants to a tested intervention. The registered 727 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower).
The record links to 0 conditions, and to 1 intervention - of which Motivational interviewing intervention arm is the first listed.
NCT03985098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03985098 about?
NCT03985098 is a clinical study titled "Motivational Interviewing (MI) Intervention to Improve Adherence". The purpose of this study is to examine the effectiveness of a telephone motivational interviewing intervention by pharmacy students in enhancing adherence to angiotensin converting enzyme inhibitors (ACEI)/ angiotensin receptor blockers (ARB) (ACE/ARBs) among patients with diabetes and hypertension...
What is the current status of trial NCT03985098?
This trial is currently completed. It is a NA study. The enrollment target is 727 participants. The study started on 2019-05-29. Estimated completion is 2022-03-22.
What interventions are being tested in trial NCT03985098?
The interventions under investigation include: Motivational interviewing intervention arm (BEHAVIORAL).
Who is sponsoring clinical trial NCT03985098?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03985098's enrollment target sits among peer trials
727 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05065216 · 728 participants · Phase 2
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
- NCT05739123 · 728 participants
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
- NCT06433765 · 728 participants
A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
- NCT06660342 · 728 participants
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI